New Analyses: Adding SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Effective for Uncontrolled Asthma – Regardless of Allergy Subtype

• SPIRIVA® RESPIMAT® shown effective in the broad range of asthma patients studied who continued   to experience symptoms despite taking other asthma maintenance therapies • New analyses show improved lung function* and asthma symptom control and reduced asthma   exacerbations† for patients with allergic asthma
Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news